Latest Tenofovir/emtricitabine Stories
Human Rights Campaign calls preventive treatment plan "a critically important tool that must be part of any and all efforts to end the HIV/AIDS epidemic in the United States" WASHINGTON, Oct.
In 2012 the HIV antiretroviral drug Truvada became the first and only medication approved by the FDA for HIV prevention.
The FDA recently approved the sale and distribution of Stribild, an HIV medication that includes four different drugs in one pill. The FDA believes that Stribild offers complete treatment for infections related to HIV.
U.S. health officials recently recommended that women and straight men that are at high risk for HIV should have access to Truvada, a pill that can reduce the risk of the HIV virus for people engaging in sexual intercourse.
The FDA recently approved Truvada, which decreases the risk of HIV invention in uninfected individuals who have a high risk of contracting HIV Infection or who are engaged in sexual activities with a partner who is HIV-infected.
The fight against AIDS could get some help this summer, as the Food and Drug Administration (FDA) is expected to approve a drug used to prevent the transmission of HIV, the AIDS virus.
Pre-birth exposure to the anti-HIV drug tenofovir does not adversely affect pregnancy outcomes and does not increase birth defects, growth abnormalities, or kidney problems in infants born to African women who are HIV positive, supporting the use of this drug during pregnancy.
A drug that has been shown to prevent HIV infection in a significant number of cases must be combined with behavioral approaches if the U.S. health care establishment is to succeed in reducing the spread of the virus.
UC San Diego (UCSD) is among three teams of investigators undertaking a four-year study testing an HIV prevention pill among people at high risk for the condition, reports Janet Lavelle for UT San Diego.